Immune complex processing in patients with systemic lupus erythematosus. In vivo imaging and clearance studies.

K A Davies; A M Peters; H L Beynon; M J Walport

doi:10.1172/JCI116090

Rheumatology Unit, Hammersmith Hospital, London, United Kingdom.

Find articles by Davies, K. in: PubMed | Google Scholar

Rheumatology Unit, Hammersmith Hospital, London, United Kingdom.

Find articles by Peters, A. in: PubMed | Google Scholar

Rheumatology Unit, Hammersmith Hospital, London, United Kingdom.

Find articles by Beynon, H. in: PubMed | Google Scholar

Rheumatology Unit, Hammersmith Hospital, London, United Kingdom.

Find articles by Walport, M. in: PubMed | Google Scholar

Published in Volume 90, Issue 5 on November 1, 1992
J Clin Invest. 1992;90(5):2075–2083. https://doi.org/10.1172/JCI116090.
© 1992 The American Society for Clinical Investigation

Published November 1, 1992 - Version history

Abnormal processing of immune complexes (IC) may be important in the pathogenesis of systemic lupus erythematosus (SLE). The clearance of large soluble IC (comprising hepatitis B surface antigen (HBsAg)/anti-HBsAg) radiolabeled with 123I was examined in 12 normal subjects and 10 patients with SLE. IC localization was analyzed by static and dynamic gamma-scintigraphy. Initial IC clearance from blood was more rapid in patients (median t1/2 = 2.15 min) than normals (median t1/2 = 5.15 min) due to more rapid uptake in the liver. However, in the SLE group, up to 12% of complexes were released from the liver after 30-50 min. Splenic uptake of immune complexes was reduced in the patients and there was reduced ability to retain IC in this organ. Plasma complement levels and erythrocyte complement receptor type 1 numbers were reduced in the patients, resulting in defective opsonization of IC and reduced red cell binding in vivo. These observations support the hypothesis that IC handling is abnormal in SLE.

Images.